Sarah Guerrette, APRN
Nurse Practitioner · Powell, TNNPI 1790207785
Payments from drug & device makers
Across 384 payments — averaging $17.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Novartis$1K
- E.r. Squibb & Sons, L.L.C.$817
- Sun Pharmaceutical Industries Inc.$442
- Johnson & Johnson$422
- Almirall LLC$259
- plus $2K from 19 others
What the payments were for
- Food & beverage$6,48797%
- Education$2033%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 107 | $1,548 |
| Novartis | 57 | $1,185 |
| E.r. Squibb & Sons, L.L.C. | 56 | $817 |
| Sun Pharmaceutical Industries Inc. | 23 | $442 |
| Johnson & Johnson | 20 | $422 |
| Almirall LLC | 13 | $259 |
| Sanofi | 10 | $255 |
| Regeneron Healthcare Solutions, Inc. | 9 | $251 |
| Pfizer | 16 | $249 |
| LEO Pharma Inc. | 16 | $220 |
| Lilly USA, LLC | 13 | $208 |
| Amgen | 9 | $199 |
| Mayne Pharma Commercial LLC | 7 | $118 |
| UCB, Inc. | 6 | $108 |
| Arcutis Biotherapeutics, Inc. | 5 | $78 |
| Incyte Corporation | 4 | $72 |
| Galderma Laboratories, L.p. | 3 | $61 |
| Mallinckrodt Hospital Products Inc. | 1 | $37 |
| Genentech USA, Inc. | 2 | $37 |
| EPI Health, LLC | 2 | $33 |
| Biofrontera Inc. | 1 | $25 |
| Organon | 1 | $20 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
How this compares
$6,690 in reported general payments places this provider in the 90th percentile of 2,662 nurse practitioner providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 15 | $1,030 |
| Metronidazole | 17 | $965 |
| Betamethasone Dipropionate | 19 | $850 |
| Ketoconazole | 67 | $802 |
| Mometasone Furoate | 35 | $647 |
| Fluocinolone Acetonide | 11 | $551 |
| Doxycycline Hyclate | 33 | $453 |
| Triamcinolone Acetonide | 54 | $402 |
| Clindamycin Phosphate | 14 | $316 |
| CiclopiroxCiclopirox Olamine | 14 | $314 |
| Mupirocin | 22 | $147 |
| Nystatin | 11 | $120 |
| Hydrocortisone | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Powell
- April BryantPowell$17K
- Deborah GrafPowell$14K
- Anita ScheimanPowell$14K
- Amy HatcherMurfreesboro$1.1M
- Karen RodenKnoxville$265K
- Susan UtleyNashville$194K
- Whitney EricksonMemphis$159K
- Erica HembreeKnoxville$125K
- Brooke FaughtNashville$89K
- Lauren WelchNashville$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.